Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Eisai Inc.
CStone Pharmaceuticals
Deciphera Pharmaceuticals, LLC
Merck Sharp & Dohme LLC
GlaxoSmithKline
Hoffmann-La Roche
AstraZeneca
RayzeBio, Inc.
Deciphera Pharmaceuticals, LLC
Pfizer
Incyte Corporation
Bristol-Myers Squibb
Bristol-Myers Squibb
3D Medicines
AstraZeneca
Novartis
Novartis